![Claude Nicaise](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claude Nicaise
Président chez
FILANA THERAPEUTICS, INC.
Fortune : 719 328 $ au 31/07/2026
Profil
Dr. Claude Nicaise, MD, is a Chairman at Filana Therapeutics, Inc., an Independent Director at Chemomab Therapeutics Ltd., an Independent Director at Gain Therapeutics, Inc., an Independent Director at Minoryx Therapeutics SL, an Independent Director at Sarepta Therapeutics, Inc., an Owner at Clinical Regulatory Services LLC, a Member at American Society for Microbiology, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology and a Member at European Society for Medical Oncology.
He is on the Board of Directors at Chemomab Therapeutics Ltd., Gain Therapeutics, Inc., Minoryx Therapeutics SL and Sarepta Therapeutics, Inc. Dr. Nicaise was previously employed as a Head-Research & Development by Ovid Therapeutics, Inc., a Senior Vice President-Global Regulatory Affairs by Alexion Pharmaceuticals, Inc., a Vice President-Global Development by Bristol Myers Squibb Co., a VP-Clinical Development & Regulatory Affairs by Formula Pharmaceuticals, Inc., and a Deputy Medical Officer by Outlook Therapeutics, Inc. He received his doctorate degree from Université Libre de Bruxelles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 48 407 ( 0,05 % ) | 719 328 $ | 31/07/2026 | |
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 13/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 15/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Claude Nicaise
| Sociétés | Poste | Début |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/06/2015 |
| GAIN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2021 |
| CHEMOMAB THERAPEUTICS LTD. | Directeur/Membre du Conseil | 16/03/2021 |
| FILANA THERAPEUTICS, INC. | Président | 09/09/2024 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | 13/07/2009 |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | 13/07/2009 |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services Provides professional education services | Corporate Officer/Principal | 13/07/2009 |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | 13/07/2009 |
Clinical Regulatory Services LLC | Fondateur | 01/01/2014 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Claude Nicaise
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Formation de Claude Nicaise
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Cassava Sciences, Inc.
 Cassava Sciences, Inc. BiotechnologyHealth Technology Manufactures and markets therapeutic products to detect and treat neurodegenerative diseases | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
American Society for Microbiology
American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services Provides professional education services | Commercial Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Formula Pharmaceuticals, Inc.
 Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops chimeric antigen receptor immunotherapy platform | Technology Services |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Clinical Regulatory Services LLC | |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Chemomab Therapeutics Ltd.
 Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
